Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study

Patients with inflammatory bowel disease (IBD) present a higher risk of developing cardiovascular diseases (CVDs) due to chronic inflammation, which plays an essential role in atherogenesis. Hyperlipidemia is another risk factor for CVDs; however, the association between IBD, IBD medications, and hy...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Subjects:	inflammatory bowel disease (IBD) IBD medications hyperlipidemia Longitudinal Health Insurance Database (LHID) lipogenesis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.910623/full